Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical Investigations (Human)

  • You have access
    Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions
    Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe A. Haberkorn and Manuel Röhrich
    Journal of Nuclear Medicine May 26, 2022, jnumed.122.264069; DOI: https://doi.org/10.2967/jnumed.122.264069
  • You have access
    18F-Fluorodihydroxyphenylalanine PET/CT at the Forefront for Initial and/or Pre-surgical Evaluation of Small Intestine Neuroendocrine Tumors
    Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale
    Journal of Nuclear Medicine May 19, 2022, jnumed.122.263984; DOI: https://doi.org/10.2967/jnumed.122.263984
  • You have access
    First-in-Human PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
    Mathias Loft, Camilla Christensen, Malene Martini Clausen, Esben Andreas Carlsen, Carsten Palnaes Hansen, Niels Kroman, Seppo Wang Langer, Claus Hoegdall, Jacob Madsen, Nic Gillings, Carsten Haagen Nielsen, Thomas Levin Klausen, Soeren Holm, Annika Loft, Anne Kiil Berthelsen and Andreas Kjaer
    Journal of Nuclear Medicine May 19, 2022, jnumed.122.264068; DOI: https://doi.org/10.2967/jnumed.122.264068
  • You have access
    Safety and efficacy of holmium-166 radioembolization in hepatocellular carcinoma – the HEPAR Primary study
    Margot Thea Maria Reinders, Karel J. van Erpecum, Maarten L. J. Smits, Arthur Johannes Anthonius Theodorus Braat, Joep de Bruijne, Rutger C.G. Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker and Marnix Lam
    Journal of Nuclear Medicine May 19, 2022, jnumed.122.263823; DOI: https://doi.org/10.2967/jnumed.122.263823
  • You have access
    Total-Body 18F-FDG PET/CT in Autoimmune Inflammatory Arthritis at Ultra-Low Dose: Initial Observations
    Yasser Abdelhafez, Siba P. Raychaudhuri, Dario Mazza, Soumajyoti Sarkar, Heather L. Hunt, Kristin McBride, Mike Nguyen, Denise T. Caudle, Benjamin A. Spencer, Negar A. Omidvari, Heejung Bang, Simon R. Cherry, Lorenzo Nardo, Ramsey Derek Badawi and Abhijit J Chaudhari
    Journal of Nuclear Medicine May 19, 2022, jnumed.121.263774; DOI: https://doi.org/10.2967/jnumed.121.263774
  • You have access
    Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice.
    Chloé S Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R Sautois and Nadia Withofs
    Journal of Nuclear Medicine May 12, 2022, jnumed.121.263611; DOI: https://doi.org/10.2967/jnumed.121.263611
  • You have access
    Correlation of 68Ga-RM2 PET with Post-Surgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
    Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
    Journal of Nuclear Medicine May 12, 2022, jnumed.122.263971; DOI: https://doi.org/10.2967/jnumed.122.263971
  • You have access
    18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
    Konstantin Messerschmidt, Henryk Barthel, Matthias Brendel, Cordula Scherlach, Karl-Titus Hoffmann, Boris-Stephan Rauchmann, Michael Rullmann, Kenneth Marek, Victor L. Villemagne, Jost-Julian Rumpf, Dorothee Saur, Matthias L. Schroeter, Andreas Schildan, Marianne Patt, Leonie Beyer, Mengmeng Song, Carla Palleis, Sabrina Katzdobler, Urban M. Fietzek, Gesine Respondek, Maximilian Scheifele, Alexander Nitschmann, Christian Zach, Olivier Barret, Jennifer Madonia, David Russell, Andrew W Stephens, Norman Koglin, Sigrun Roeber, Jochen Herms, Kai Boetzel, Peter Bartenstein, Johannes Levin, John P. Seibyl, Günter Höglinger, Joseph Classen and Osama Sabri
    Journal of Nuclear Medicine May 5, 2022, jnumed.121.262854; DOI: https://doi.org/10.2967/jnumed.121.262854
  • You have access
    68Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment
    Farshad Moradi, Heying Duan, Hong Song, Guido A Davidzon, Benjamin I Chung, Alan E C Thong, Andreas M Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
    Journal of Nuclear Medicine May 5, 2022, jnumed.122.263897; DOI: https://doi.org/10.2967/jnumed.122.263897
  • You have access
    89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer
    Sarah R Verhoeff, Pim P van de Donk, Erik H.J.G. Aarntzen, Sjoukje F Oosting, Adrienne H Brouwers, Iris H.C. Miedema, Jens Voortman, Willemien C. Menke-van der Houven van Oordt, Ronald Boellaard, Dennis Vriens, Marije Slingerland, Rick Hermsen, Ilse van Engen-van Grunsven, Sandra Heskamp and Carla M.L. van Herpen
    Journal of Nuclear Medicine May 5, 2022, jnumed.121.263470; DOI: https://doi.org/10.2967/jnumed.121.263470

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire